{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:39:22Z","timestamp":1791117562464,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,12,3]],"date-time":"2006-12-03T00:00:00Z","timestamp":1165104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1038\/ni1415","type":"journal-article","created":{"date-parts":[[2006,12,3]],"date-time":"2006-12-03T13:28:05Z","timestamp":1165152485000},"page":"74-83","source":"Crossref","is-referenced-by-count":280,"title":["Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Eun Mi","family":"Hur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Edward","family":"Haws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,3]]},"reference":[{"key":"BFni1415_CR1","unstructured":"National Institutes of Health Autoimmune Disease Coordinating Committee Report (The National Institutes of Health, Bethesda, Maryland 2002)."},{"key":"BFni1415_CR2","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1172\/JCI12980","volume":"107","author":"DT Denhardt","year":"2001","unstructured":"Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D. & Berman, J.S. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107, 1055\u20131061 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFni1415_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/ni1327","volume":"7","author":"ML Shinohara","year":"2006","unstructured":"Shinohara, M.L. et al. Osteopontin expression is essential for interferon-\u03b1 production by plasmacytoid dendritic cells. Nat. Immunol. 7, 498\u2013506 (2006).","journal-title":"Nat. Immunol."},{"key":"BFni1415_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.1062960","volume":"294","author":"D Chabas","year":"2001","unstructured":"Chabas, D. et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731\u20131735 (2001).","journal-title":"Science"},{"key":"BFni1415_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jneuroim.2004.09.004","volume":"158","author":"M Comabella","year":"2005","unstructured":"Comabella, M. et al. Plasma osteopontin levels in multiple sclerosis. J. Neuroimmunol. 158, 231\u2013239 (2005).","journal-title":"J. Neuroimmunol."},{"key":"BFni1415_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/rheumatology\/keh558","volume":"44","author":"CK Wong","year":"2005","unstructured":"Wong, C.K., Lit, L.C., Tam, L.S., Li, E.K. & Lam, C.W. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44, 602\u2013606 (2005).","journal-title":"Rheumatology (Oxford)"},{"key":"BFni1415_CR7","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.147.9.2902","volume":"147","author":"MA Lampe","year":"1991","unstructured":"Lampe, M.A., Patarca, R., Iregui, M.V. & Cantor, H. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J. Immunol. 147, 2902\u20132906 (1991).","journal-title":"J. Immunol."},{"key":"BFni1415_CR8","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1172\/JCI200523273","volume":"115","author":"G Xu","year":"2005","unstructured":"Xu, G. et al. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J. Clin. Invest. 115, 1060\u20131067 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFni1415_CR9","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1182\/blood-2003-05-1748","volume":"103","author":"A Chiocchetti","year":"2004","unstructured":"Chiocchetti, A. et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity\/lymphoproliferation. Blood 103, 1376\u20131382 (2004).","journal-title":"Blood"},{"key":"BFni1415_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/gut.2004.048298","volume":"54","author":"T Sato","year":"2005","unstructured":"Sato, T. et al. Osteopontin\/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 54, 1254\u20131262 (2005).","journal-title":"Gut"},{"key":"BFni1415_CR11","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.4049\/jimmunol.168.5.2096","volume":"168","author":"M Jansson","year":"2002","unstructured":"Jansson, M., Panoutsakopoulou, V., Baker, J., Klein, L. & Cantor, H. Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1\/osteopontin-deficient mice. J. Immunol. 168, 2096\u20132099 (2002).","journal-title":"J. Immunol."},{"key":"BFni1415_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.06.007","volume":"155","author":"MH Vogt","year":"2004","unstructured":"Vogt, M.H. et al. Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients. J. Neuroimmunol. 155, 155\u2013160 (2004).","journal-title":"J. Neuroimmunol."},{"key":"BFni1415_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1126\/science.287.5454.860","volume":"287","author":"S Ashkar","year":"2000","unstructured":"Ashkar, S. et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287, 860\u2013864 (2000).","journal-title":"Science"},{"key":"BFni1415_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0167-5699(00)01715-1","volume":"21","author":"AW O'Regan","year":"2000","unstructured":"O'Regan, A.W., Nau, G.J., Chupp, G.L. & Berman, J.S. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol. Today 21, 475\u2013478 (2000).","journal-title":"Immunol. Today"},{"key":"BFni1415_CR15","doi-asserted-by":"publisher","first-page":"17101","DOI":"10.1073\/pnas.0508666102","volume":"102","author":"ML Shinohara","year":"2005","unstructured":"Shinohara, M.L. et al. T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc. Natl. Acad. Sci. USA 102, 17101\u201317106 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1415_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1083\/jcb.141.4.1083","volume":"141","author":"M Scatena","year":"1998","unstructured":"Scatena, M. et al. NF-\u03baB mediates \u03b1v\u03b23 integrin-induced endothelial cell survival. J. Cell Biol. 141, 1083\u20131093 (1998).","journal-title":"J. Cell Biol."},{"key":"BFni1415_CR17","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1128\/MCB.20.8.2734-2742.2000","volume":"20","author":"YH Lin","year":"2000","unstructured":"Lin, Y.H. et al. Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor. Mol. Cell. Biol. 20, 2734\u20132742 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFni1415_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nri701","volume":"2","author":"LS Walker","year":"2002","unstructured":"Walker, L.S. & Abbas, A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2, 11\u201319 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni1415_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0022-510X(91)90219-W","volume":"104","author":"MP Pender","year":"1991","unstructured":"Pender, M.P., Nguyen, K.B., McCombe, P.A. & Kerr, J.F. Apoptosis in the nervous system in experimental allergic encephalomyelitis. J. Neurol. Sci. 104, 81\u201387 (1991).","journal-title":"J. Neurol. Sci."},{"key":"BFni1415_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0166-2236(97)01079-5","volume":"20","author":"R Gold","year":"1997","unstructured":"Gold, R., Hartung, H.P. & Lassmann, H. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 20, 399\u2013404 (1997).","journal-title":"Trends Neurosci."},{"key":"BFni1415_CR21","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1002\/eji.1830241107","volume":"24","author":"Z Tabi","year":"1994","unstructured":"Tabi, Z., McCombe, P.A. & Pender, M.P. Apoptotic elimination of V\u03b28.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V\u03b28.2+ encephalitogenic T cells. Eur. J. Immunol. 24, 2609\u20132617 (1994).","journal-title":"Eur. J. Immunol."},{"key":"BFni1415_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/ni0901-762","volume":"2","author":"L Steinman","year":"2001","unstructured":"Steinman, L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2, 762\u2013764 (2001).","journal-title":"Nat. Immunol."},{"key":"BFni1415_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1084\/jem.20021603","volume":"197","author":"E Bettelli","year":"2003","unstructured":"Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073\u20131081 (2003).","journal-title":"J. Exp. Med."},{"key":"BFni1415_CR24","doi-asserted-by":"publisher","first-page":"28593","DOI":"10.1074\/jbc.M303445200","volume":"278","author":"R Das","year":"2003","unstructured":"Das, R., Mahabeleshwar, G.H. & Kundu, G.C. Osteopontin stimulates cell motility and nuclear factor \u03baB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase\/Akt signaling pathways in breast cancer cells. J. Biol. Chem. 278, 28593\u201328606 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFni1415_CR25","doi-asserted-by":"publisher","first-page":"46024","DOI":"10.1074\/jbc.M105132200","volume":"276","author":"YH Lin","year":"2001","unstructured":"Lin, Y.H. & Yang-Yen, H.F. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase\/Akt signaling pathway. J. Biol. Chem. 276, 46024\u201346030 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFni1415_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","volume":"96","author":"A Brunet","year":"1999","unstructured":"Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857\u2013868 (1999).","journal-title":"Cell"},{"key":"BFni1415_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/35008115","volume":"404","author":"RH Medema","year":"2000","unstructured":"Medema, R.H., Kops, G.J., Bos, J.L. & Burgering, B.M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404, 782\u2013787 (2000).","journal-title":"Nature"},{"key":"BFni1415_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0092-8674(04)00302-2","volume":"117","author":"MC Hu","year":"2004","unstructured":"Hu, M.C. et al. I\u03baB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117, 225\u2013237 (2004).","journal-title":"Cell"},{"key":"BFni1415_CR29","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","volume":"24","author":"A Essafi","year":"2005","unstructured":"Essafi, A. et al. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24, 2317\u20132329 (2005).","journal-title":"Oncogene"},{"key":"BFni1415_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.0105-2896.2006.00375.x","volume":"210","author":"A Hoffmann","year":"2006","unstructured":"Hoffmann, A. & Baltimore, D. Circuitry of nuclear factor \u03baB signaling. Immunol. Rev. 210, 171\u2013186 (2006).","journal-title":"Immunol. Rev."},{"key":"BFni1415_CR31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.it.2004.08.012","volume":"25","author":"A Strasser","year":"2004","unstructured":"Strasser, A. & Pellegrini, M. T-lymphocyte death during shutdown of an immune response. Trends Immunol. 25, 610\u2013615 (2004).","journal-title":"Trends Immunol."},{"key":"BFni1415_CR32","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1097-2765(01)00320-3","volume":"8","author":"EH Cheng","year":"2001","unstructured":"Cheng, E.H. et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8, 705\u2013711 (2001).","journal-title":"Mol. Cell"},{"key":"BFni1415_CR33","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1146\/annurev.immunol.22.012703.104554","volume":"22","author":"P Marrack","year":"2004","unstructured":"Marrack, P. & Kappler, J. Control of T cell viability. Annu. Rev. Immunol. 22, 765\u2013787 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni1415_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/17135","volume":"397","author":"SA Susin","year":"1999","unstructured":"Susin, S.A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441\u2013446 (1999).","journal-title":"Nature"},{"key":"BFni1415_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1126\/science.1115035","volume":"311","author":"SA Lakhani","year":"2006","unstructured":"Lakhani, S.A. et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 311, 847\u2013851 (2006).","journal-title":"Science"},{"key":"BFni1415_CR36","doi-asserted-by":"publisher","first-page":"11573","DOI":"10.1073\/pnas.0603007103","volume":"103","author":"C Munoz-Pinedo","year":"2006","unstructured":"Munoz-Pinedo, C. et al. Different mitochondrial intermembrane space proteins are released during apoptosis in a manner that is coordinately initiated but can vary in duration. Proc. Natl. Acad. Sci. USA 103, 11573\u201311578 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni1415_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0092-8674(02)01046-2","volume":"111","author":"SA Lipton","year":"2002","unstructured":"Lipton, S.A. & Bossy-Wetzel, E. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell 111, 147\u2013150 (2002).","journal-title":"Cell"},{"key":"BFni1415_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev.neuro.25.112701.142913","volume":"25","author":"L Steinman","year":"2002","unstructured":"Steinman, L., Martin, R., Bernard, C., Conlon, P. & Oksenberg, J.R. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25, 491\u2013505 (2002).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFni1415_CR39","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/365642a0","volume":"365","author":"S Brocke","year":"1993","unstructured":"Brocke, S. et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365, 642\u2013644 (1993).","journal-title":"Nature"},{"key":"BFni1415_CR40","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.183.4.1777","volume":"183","author":"M Yu","year":"1996","unstructured":"Yu, M., Johnson, J.M. & Tuohy, V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183, 1777\u20131788 (1996).","journal-title":"J. Exp. Med."},{"key":"BFni1415_CR41","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jneuroim.2005.04.006","volume":"164","author":"PA Smith","year":"2005","unstructured":"Smith, P.A. et al. Epitope spread is not critical for the relapse and progression of MOG 8\u201321 induced EAE in Biozzi ABH mice. J. Neuroimmunol. 164, 76\u201384 (2005).","journal-title":"J. Neuroimmunol."},{"key":"BFni1415_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0165-5728(03)00005-5","volume":"136","author":"DS Skundric","year":"2003","unstructured":"Skundric, D.S. et al. Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsing-remitting EAE in H-2b\/s mice. J. Neuroimmunol. 136, 34\u201345 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFni1415_CR43","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0952-7915(00)00093-5","volume":"12","author":"G Screaton","year":"2000","unstructured":"Screaton, G. & Xu, X.N. T cell life and death signalling via TNF-receptor family members. Curr. Opin. Immunol. 12, 316\u2013322 (2000).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni1415_CR44","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1038\/sj.onc.1208922","volume":"24","author":"JJ Letterio","year":"2005","unstructured":"Letterio, J.J. TGF-\u03b2 signaling in T cells: roles in lymphoid and epithelial neoplasia. Oncogene 24, 5701\u20135712 (2005).","journal-title":"Oncogene"},{"key":"BFni1415_CR45","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0002-9440(10)65330-8","volume":"154","author":"XQ Yu","year":"1999","unstructured":"Yu, X.Q. et al. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am. J. Pathol. 154, 833\u2013841 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFni1415_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.4049\/jimmunol.167.2.749","volume":"167","author":"EM Palmer","year":"2001","unstructured":"Palmer, E.M., Farrokh-Siar, L., Maguire van Seventer, J. & van Seventer, G.A. IL-12 decreases activation-induced cell death in human naive Th cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function. J. Immunol. 167, 749\u2013758 (2001).","journal-title":"J. Immunol."},{"key":"BFni1415_CR47","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/sj.leu.2403496","volume":"18","author":"J Han","year":"2004","unstructured":"Han, J. et al. Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells. Leukemia 18, 1671\u20131680 (2004).","journal-title":"Leukemia"},{"key":"BFni1415_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1006\/cimm.2001.1800","volume":"210","author":"B Adler","year":"2001","unstructured":"Adler, B., Ashkar, S., Cantor, H. & Weber, G.F. Costimulation by extracellular matrix proteins determines the response to TCR ligation. Cell. Immunol. 210, 30\u201340 (2001).","journal-title":"Cell. Immunol."},{"key":"BFni1415_CR49","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1084\/jem.191.12.2053","volume":"191","author":"BM Wittig","year":"2000","unstructured":"Wittig, B.M., Johansson, B., Zoller, M., Schwarzler, C. & Gunthert, U. Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J. Exp. Med. 191, 2053\u20132064 (2000).","journal-title":"J. Exp. Med."},{"key":"BFni1415_CR50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature01158","volume":"420","author":"S Youssef","year":"2002","unstructured":"Youssef, S. et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420, 78\u201384 (2002).","journal-title":"Nature"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni1415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni1415","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni1415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T12:56:35Z","timestamp":1707396995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni1415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["BFni1415"],"URL":"https:\/\/doi.org\/10.1038\/ni1415","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,3]]}}}